No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Instruments & Supplies
St.Shine Optical Co.,Ltd., headquartered in New Taipei City, Taiwan, is a prominent entity involved in the manufacturing, distribution, and sales of ophthalmic products, including contact lenses and optical lenses. The company's reach extends across diverse global markets, encompassing Asia, Europe, America, and Taiwan. Its extensive product portfolio features a variety of soft contact lenses, such as daily disposable, frequent replacement, and colored options, alongside advanced silicone hydrogel and traditional cast-molded types. These offerings are primarily marketed under the Ticon brand. The core purpose of their products is to rectify common vision impairments, specifically addressing refractive errors like myopia (nearsightedness), hyperopia (farsightedness), and astigmatism. Established in 1986, the firm initially operated under the name First Optical Co., Ltd., adopting its current corporate identity, St.Shine Optical Co.,Ltd., in the same year.
www.stshine.com.twNo one on the platform currently holds 1565.TWO.
No tracked institution reports a position in 1565.TWO as of their last filing.
No one on the platform has traded 1565.TWO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 8.9% | 14.4% | — | — | — | |
| Rev. Growth % | -9.5% | -3.8% | ||||
| Profit Margin % | 11.1% | 15.6% | ||||
| Free Cash Flow Margin % | 12.3% | 18.9% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $3.6B | -13.0% | $4.96 | $4.96–$4.96 | — | 1 |
| 2027 | $3.7B | +3.1% | $4.69 | $4.69–$4.69 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-06 | $1.07 | $1.61 | +50.5% |
| 2026-05-07 | $2.17 | $1.39 | -35.9% |
| 2026-03-10 | $2.30 | $2.34 | +1.7% |
| 2025-11-06 | $2.54 | $2.68 | +5.5% |
| 2025-08-07 | $2.74 | $0.57 | -79.2% |
| 2025-05-08 | $3.65 | $3.43 | -6.0% |
| 2025-03-12 | $4.07 | $4.49 | +10.3% |
| 2024-11-07 | $2.96 | $3.88 | +31.1% |
| +0.00% |
| $7.7B |
| — |
| 4119.TWSCI Pharmtech, Inc. | $59.80 | +0.34% | $7.1B | — |
| 4126.TWOPacific Hospital Supply Co., Ltd | $78.00 | +0.39% | $5.7B | — |
Source: Financial Modeling Prep · peers by sector/industry